Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-01-12 pm EST			5-day change	1st Jan Change
1,081.00 ^USD	+1.64%		+3.79%	+0.59%

07:41pm	Amgen says MariTide helped trial patients maintain weight loss	RE
06:46pm	Amgen to announce data on obesity drug MariTide at healthcare conference	RE

Sector Update: Health Care Stocks Edge Higher Friday Afternoon

Published on 12/12/2025 at 01:58 pm EST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Eli Lilly and Company

07:41pm	Amgen says MariTide helped trial patients maintain weight loss	RE
06:46pm	Amgen to announce data on obesity drug MariTide at healthcare conference	RE
06:42pm	Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra	RE
Jan. 12	Novo Nordisk sees pills capturing over third of GLP-1 obesity market by 2030	RE
Jan. 12	Sector Update: Tech Stocks Gain Late Afternoon	MT
Jan. 12	Sector Update: Tech Stocks Higher Monday Afternoon	MT
Jan. 12	CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program	CI
Jan. 12	European Stocks Close Mostly Higher in Monday Trading; BHP Not Planning to Bid on Glencore	MT
Jan. 12	NVIDIA and Eli Lilly and Company Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI	CI
Jan. 12	France Says Yet to Receive Investment Screening Dossier from Lilly Over Potential Abivax Bid	MT
Jan. 12	Nvidia, Lilly Launching AI Lab for Drug Discovery Projects	MT
Jan. 12	Lilly will have supply of new weight loss pill for many countries, exec says	RE
Jan. 12	France denies contact with Eli Lilly over reported $17.5 billion Abivax deal	RE
Jan. 12	French Government Says Eli Lilly Made No Contact Regarding Abivax Takeover	MT
Jan. 12	Nvidia, Eli Lilly to Launch AI-Powered Co-Innovation Lab -- Update	DJ
Jan. 12	Nvidia, Eli Lilly to Launch AI-Powered Co-Innovation Lab	DJ
Jan. 12	Analyst recommendations: Exxon Mobil, AbbVie, Eli Lilly, JD Sports…
Jan. 12	Abivax Surges on Takeover Rumors, French Finance Ministry Not Informed	RE
Jan. 12	Nvidia and Lilly announce co-innovation AI lab to reinvent drug discovery in the age of AI	RE
Jan. 12	Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab	RE
Jan. 12	Nvidia, Eli Lilly to spend $1 billion on joint lab that will use Nvidia Vera Rubin AI chips	RE
Jan. 12	France has had no request for investment approval in biotech Abivax - official	RE
Jan. 12	France: Bercy Not Informed of Any Request Regarding Abivax, Sought After by Eli Lilly	RE
Jan. 12	SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs	RE
Jan. 12	Sector Update: Health Care Stocks Lower Pre-Bell Monday	MT

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.4%); - immunology diseases (9.8%); - neurology (3.3%): primarily drugs used in treating depression and schizophrenia; - other (2%). Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Employees

47,000

Sector

Pharmaceuticals

Calendar

05:15pm - J.P. Morgan Healthcare Conference

More about the company